Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Su

Showing results (321-330 of 394) with videos related to

Pageof 40
Sort By:
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
Cell Transplantation|October 8, 2020
Transplantation of Adipose-Derived Stem Cells Alleviates Striatal Degeneration in a Transgenic Mouse Model for Multiple System AtrophyChristine Chang, Jen-Wei Liu, Bo Cheng Chen, et al.
Ecotoxicology and Environmental Safety|February 22, 2021
Genotoxic effects of 1-nitropyrene in macrophages are mediated through a p53-dependent pathway involving cytochrome c release, caspase activation, and PARP-1 cleavageSheng-Wen Wu, Chun-Hung Su, Yung-Chuan Ho, et al.
Antiviral Therapy|February 4, 2012
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapyChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 24, 2025
Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseasesTai-Chung Tseng, Yao-Chun Hsu, Tung-Hung Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 20, 2023
Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antiviralsChen-Hua Liu, Yih-Sharng Chen, Meng-Kun Tsai, et al.
The American Journal of Gastroenterology|February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|May 27, 2017
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patientsChen-Hua Liu, Chun-Jen Liu, Chun-Ming Hong, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2021
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Hepatology (Baltimore, Md.)|March 20, 2025
Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patientsTai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, et al.
Pageof 40

Showing results (321-330 of 394) with videos related to

Sort By:
Pageof 40
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
Cell Transplantation|October 8, 2020
Transplantation of Adipose-Derived Stem Cells Alleviates Striatal Degeneration in a Transgenic Mouse Model for Multiple System AtrophyChristine Chang, Jen-Wei Liu, Bo Cheng Chen, et al.
Ecotoxicology and Environmental Safety|February 22, 2021
Genotoxic effects of 1-nitropyrene in macrophages are mediated through a p53-dependent pathway involving cytochrome c release, caspase activation, and PARP-1 cleavageSheng-Wen Wu, Chun-Hung Su, Yung-Chuan Ho, et al.
Antiviral Therapy|February 4, 2012
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapyChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 24, 2025
Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseasesTai-Chung Tseng, Yao-Chun Hsu, Tung-Hung Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 20, 2023
Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antiviralsChen-Hua Liu, Yih-Sharng Chen, Meng-Kun Tsai, et al.
The American Journal of Gastroenterology|February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|May 27, 2017
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patientsChen-Hua Liu, Chun-Jen Liu, Chun-Ming Hong, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2021
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Hepatology (Baltimore, Md.)|March 20, 2025
Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patientsTai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, et al.
Pageof 40